Frontlight ResearchEarly access
Trial site
Shanghai Jiaotong University School of Medicine Ruijin Hospital
- 6running trials
- 6closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis3 trials
- Chronic lymphocytic leukaemia2 trials
- Pancreatic cancer2 trials
- Asthma1 trial
- Charcot-Marie-Tooth disease1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Haemophilia1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 310 trials
- Phase 1/22 trials
- Status
- Completed6 trials
- Active, not recruiting4 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Jacobio Pharmaceuticals Co., Ltd.2 trials
- Loxo Oncology, Inc.2 trials
- ALK-Abelló A/S1 trial
- Chipscreen Biosciences, Ltd.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Pancreatic cancer2 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
Closed trials
Completed
Completed
Completed
A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026